Written by Conor Hale
Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.
The $240 million cash deal would not only add product portfolios covering shoulder replacements as well as reconstructions of the hand, wrist, elbow, ankle and foot, it would also bring in a dedicated sales force and distributors spanning the U.S., Canada and Europe.
The acquisition would also give Smith & Nephew access to Integra’s next-generation shoulder replacement system, currently under development and slated for a 2022 commercial launch.
“This strategic acquisition represents a significant opportunity to strengthen Smith & Nephew’s position in a high-value area and allows us to offer a leading extremities portfolio to customers,” said Skip Kiil, president of global orthopedics at Smith & Nephew, which has pegged the growth of the U.S. extremities market at about 6% to 7% per year.
Read more here